Search Results

24 Results for "genervon".

Sort By

Biotech Beach

Genervon Presents Innovative CNS Drug Candidate at 2018 BIO CEO & Investor Conference

Introduced Genervon’s guiding hypothesis that multi-target drug development is the key to curing complex neurological disorders.

February 26, 2018
·
2 min read
Biotech Beach

Genervon’s GM604 Is a Multi-Target Regulator That Provides a Novel Treatment Strategy for ALS

Genervon is presenting its recent findings at the 28th national symposium on ALS/MND in Boston on Saturday, December 9, 2017.

December 8, 2017
·
2 min read
Drug Development

Genervon Presents Mechanisms of Actions in Alzheimer’s Disease, Including Results Confirming that GM6 Attenuates Alzheimer’s Disease in Mouse Model, in Part by Reducing Inflammation

Following the closure of several research programs for Alzheimer’s disease, in early 2018 the FDA issued a release entitled “Draft Guidance for Industry: Early Alzheimer’s Disease: Developing Drugs for Treatment.”

September 25, 2018
·
2 min read
Drug Development

Confidential Data From Genervon ALS Phase IIA Clinical Trial Were Released And Published

March 23, 2017
·
2 min read
Biotech Beach

Genervon Release: GM604 To Be Granted “Orphan Drug” Status In Europe

May 3, 2016
·
1 min read
Drug Development

Genervon Announces ALS Compassionate Use Results

January 8, 2015
·
3 min read
Biotech Beach

Genervon Release: ALS And Alzheimer’s Disease Bioinformatics Reports Confirm GM6’s Role As Regulator Of Disease-Relevant Pathways

December 27, 2016
·
2 min read
Drug Development

FDA, Genervon and ALS Blogger Battle Over Clinical Trial Interpretation

April 21, 2015
·
3 min read
Drug Development

FDA Grants “Orphan Drug” Designation For Genervon’s Breakthrough Multi-Target ALS Bio-Drug GM604

March 3, 2014
·
1 min read
Drug Development

Genervon GM604 Reduced TDP-43 Protein Aggregates And Slowed Down ALS Progression

September 22, 2015
·
3 min read